摘要
对108例RVO 患者随机分为一般药物、尿激酶或蝮蛇抗栓酶溶栓、溶栓加活血化淤中药三个治疗组,观察3个月—8年,平均2年2个月。结果表明三组治疗总显效率46.3%,有效率71.3%;蝮蛇抗栓酶的疗效优于尿激酶;蝮蛇抗栓酶联合中药治疗疗效最佳,显效率75%,有效率87.5%。缺血型RVO 的预后不佳。
One kind of the general drugs,fibrinolytic agents (urokinase orahalysantinfarctase),and fibrinolytic agentscombined with traditional Chinese medicinewas randomly selected for the treatment of108 patients with retinal vein occlusion(RVO).These patients were followed upfor 2 years and 2 months (3 months to 8years).The results showed that markedlyefficiency in 50%,efficiency in 71.3%,andthe efficiency rate in ahalysantinfarctasegroup is significantly higher than theurokinase group.However,curative effect inahalysantinfarctase combined with tradi-tional Chinese medicine group is best,itsmarkedly efficiency in 75% and efficiency in87.5%.The prognosis of ischemic CRVO isnot good yet,therefore,the therapy ofischemic RVO and its complications isresearch direction in future.